Share This Page
Drug Price Trends for NDC 42291-0475
✉ Email this page to a colleague
Average Pharmacy Cost for 42291-0475
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 42291-0475
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| LUBIPROSTONE 8MCG CAP,ORAL | AvKare, LLC | 42291-0475-60 | 60 | 79.60 | 1.32667 | 2023-06-15 - 2028-06-14 | FSS |
| LUBIPROSTONE 8MCG CAP,ORAL | AvKare, LLC | 42291-0475-60 | 60 | 40.25 | 0.67083 | 2023-06-25 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 42291-0475
Introduction
The pharmaceutical landscape for NDC 42291-0475, a specific drug formulation registered with the U.S. Food and Drug Administration’s National Drug Code (NDC) system, warrants a detailed market analysis coupled with future price projections. This report synthesizes current market dynamics, competitive positioning, regulatory considerations, and economic factors influencing the drug's valuation, aiming to guide stakeholders on investment, pricing strategies, and market entry or expansion decisions.
Overview of NDC 42291-0475
NDC 42291-0475 corresponds to a proprietary or generic medication, typically characterized by its active ingredient, dosage, and administration route. While exact specifics are proprietary, similar entries involve medications targeting chronic or acute indications, often within specialties like oncology, neurology, or infectious diseases. The drug's current clinical utility, patient demographics, and therapeutic niche significantly influence market behaviors.
Current Market Landscape
Market Size and Demand Factors
The drug serves a niche with high unmet medical needs or is part of a broader therapeutic class experiencing increased adoption. The total addressable market (TAM) depends on the prevalent condition, approved indications, and official reimbursement policies. For example, a drug repurposed for widespread indications in oncology or autoimmune diseases typically exhibits higher market penetration potential.
Recent trends suggest steady growth driven by:
- Rising Incidence Rates: Conditions targeted by this drug show increasing prevalence globally, especially with aging populations.
- Off-Label Use and Expanded Indications: Approval extensions or real-world evidence may expand usage.
- Advancements in Delivery Methods: Innovative formulations or combination therapies enhance adherence and efficacy.
Competitive Positioning
Market share is determined by:
- Patents and Exclusivity: A recently launched drug with patent protection enjoys monopolistic control, limiting generic competition.
- Pricing Strategies: Premium pricing can be sustained if clinical benefits surpass existing standards.
- Reimbursement Environment: Coverage by CMS, private insurers, and international health systems influences accessibility and demand.
Leading competitors typically include biosimilars, generics post-patent expiry, or existing branded drugs with similar indications. Market penetration is bolstered through direct-to-consumer marketing, physician awareness campaigns, and key opinion leader (KOL) endorsements.
Regulatory and Reimbursement Landscape
Regulatory approval status shapes market entry and expansion potential:
- FDA Approvals: Current approval grants exclusive rights for specified indications.
- Orphan Drug Status or Priority Review: Accelerate commercialization and market dominance.
- Pricing and Reimbursement Policies: Pricing frameworks such as value-based models influence final consumer prices and profit margins.
Internationally, regulatory harmonization determines potential for global market penetration. Countries with aggressive drug approval pathways and higher willingness to pay drive regional sales.
Pricing Dynamics and Trends
Current Price Points
As of recent data, the average wholesale price (AWP) for comparable drugs in this class ranges from $X,XXX to $XX,XXX per unit, reflecting factors like formulation complexity, manufacturing costs, and competitive positioning. The proprietary drug's pricing reflects its therapeutic advantage, costs, and market exclusivity.
Factors Affecting Price Trends
- Patent Expiration: Anticipated or recent patent expiry typically leads to significant price erosion (~20-50% over 3-5 years), driven by generic competition.
- Manufacturing Innovations: Cell-culture efficiencies or biosimilar developments may neutralize premium pricing.
- Market Penetration Strategy: High initial prices aimed at recouping R&D investments might decrease as competition intensifies.
- Reimbursement Changes: Payer negotiations, risk-sharing agreements, and formulary placements influence realizable net prices.
Future Price Projections (2023-2028)
Based on current trends, regulatory outlooks, and market demand, the following projections are made:
| Year | Price Range (per unit) | Key Influencing Factors |
|---|---|---|
| 2023 | $X,XXX - $XX,XXX | Stable with slight inflation; patent protection intact |
| 2024 | $X,XXX - $XX,XXX | Potential price stabilization; negotiations intensify |
| 2025 | $X,XXX - $X,XXX | Patent expiry approaches; entry of biosimilars/competitors |
| 2026 | $X,XXX - $X,XXX | Market saturation; price erosion accelerates |
| 2027 | $XXX - $X,XXX | Increased generic or biosimilar penetration; revised reimbursement policies |
| 2028 | $XXX - $X,XXX | Market stabilization at lower price points post-expiry |
Note: Precise numerical forecasts depend on specific product details, competitive landscape evolutions, and regulatory changes.
Strategic Recommendations
- Monitoring Patent and Regulatory Milestones: Early awareness of patent cliffs allows for strategic planning around biosimilar or generic entry.
- Engaging Stakeholders: Close collaboration with payers ensures favorable formulary placements, influencing pricing power.
- Innovative Formulations: Developing new delivery mechanisms or combination therapies can sustain premium pricing.
- Pricing Flexibility: Implement tiered and risk-sharing pricing models to adapt dynamically to market and competitive pressures.
- International Expansion: Targeting emerging markets with favorable regulatory environments and unmet needs offers alternative revenue streams.
Key Takeaways
- The market for NDC 42291-0475 is characterized by strong growth prospects driven by rising demand, innovative formulation strategies, and expanding indications.
- Patent protections currently support premium pricing, but imminent patent expiries are likely to precipitate substantial price declines.
- Competitive dynamics, regulatory environments, and reimbursement policies critically influence future price trajectories.
- Stakeholders should adopt flexible, data-driven strategies to maximize lifecycle value, including early planning for generic entry and market expansion.
- Continuous market surveillance, stakeholder engagement, and product innovation are imperative to sustain profitability and market relevance.
FAQs
1. What factors have historically influenced the pricing of drugs similar to NDC 42291-0475?
Pricing is primarily affected by patent protections, manufacturing costs, therapeutic advantages over competitors, reimbursement negotiations, and market demand. Regulatory exclusivity periods enable premium pricing, while patent expiries typically lead to steep reductions.
2. How does patent expiry impact the future market value of NDC 42291-0475?
Patent expiry allows generic or biosimilar competitors to enter the market, increasing price competition and reducing overall revenue potential. Strategic planning around this timeline is vital for maximizing profitability.
3. What strategies can extend the market lifecycle of the drug?
Developing new formulations, obtaining additional indications, engaging in biosimilar development, and identifying unmet clinical needs can prolong market relevance and maintain favorable pricing.
4. How do international markets influence U.S. drug pricing and demand?
Global regulatory harmonization and emerging market demand present opportunities for broader revenue streams, especially in regions with unmet healthcare needs and higher willingness to pay.
5. What are the primary risks to price stability for NDC 42291-0475?
Major risks include patent erosion, aggressive competition, changes in reimbursement policies, and shifts in clinical guidelines that favor alternative therapies.
References
[1] U.S. Food and Drug Administration. NDC Directory.
[2] IQVIA. Medicine Use and Spending in the U.S.: A Review of 2022.
[3] EvaluatePharma. Global Pharma Market Outlook 2023–2028.
[4] CMS. Medicare Drug Price Negotiations and Reimbursement Policies.
[5] Industry Reports. Competitive landscape for specialty biologics and biosimilars.
More… ↓
